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Background-—Exercise-induced pulmonary hypertension is common in heart failure with preserved ejection fraction (HFpEF). We
hypothesized that this could result in pericardial constraint and diastolic ventricular interaction in some patients during exercise.
Methods and Results-—Contrast stress echocardiography was performed in 30 HFpEF patients, 17 hypertensive controls, and 17
normotensive controls (healthy). Cardiac volumes, and normalized radius of curvature (NRC) of the interventricular septum at end-
diastole and end-systole, weremeasured at rest and peak-exercise, and compared between the groups. The septumwas circular at rest
in all 3 groups at end-diastole. At peak-exercise, end-systolic NRC increased to 1.470.05 (P<0.001) in HFpEF patients, conﬁrming
development of pulmonary hypertension. End-diastolic NRC also increased to 1.540.07 (P<0.001) in HFpEF patients, indicating
septal ﬂattening, and this correlated signiﬁcantly with end-systolic NRC (q=0.51, P=0.007). In hypertensive controls and healthy
controls, peak-exercise end-systolic NRC increased, but this was signiﬁcantly less than observed in HFpEF patients (HFpEF, P=0.02
versus hypertensive controls; P<0.001 versus healthy). There were also small, non-signiﬁcant increases in end-diastolic NRC in both
groups (hypertensive controls, +0.170.05, P=0.38; healthy, +0.060.03, P=0.93). In HFpEF patients, peak-exercise end-diastolic
NRC also negatively correlated (r=0.40, P<0.05) with the change in left ventricular end-diastolic volume with exercise (ie, the Frank-
Starling mechanism), and a trend was noted towards a negative correlation with change in stroke volume (r=0.36, P=0.08).
Conclusions-—Exercise pulmonary hypertension causes substantial diastolic ventricular interaction on exercise in some patients
with HFpEF, and this restriction to left ventricular ﬁlling by the right ventricle exacerbates the pre-existing impaired Frank-Starling
response in these patients. ( J Am Heart Assoc. 2019;8:e010114. DOI: 10.1161/JAHA.118.010114.)
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H eart failure with preserved ejection fraction (HFpEF)accounts for approximately half of all patients with
heart failure.1 The morbidity and mortality of this syndrome is
similar to that of heart failure with reduced ejection fraction
(HFrEF)2; however, the therapeutic paradigm of blockade of
maladaptive neurohumoral activation that is the cornerstone
of treatment in HFrEF has not been successful in HFpEF.3 This
likely reﬂects a fundamental difference in pathophysiology,
explaining the lack of effective therapy for HFpEF.
While there are typically subtle abnormalities of contractile
function in HFpEF despite a normal left ventricular ejection
fraction,4 diastolic dysfunction plays the dominant role in
limiting stroke volume augmentation on exercise.5 Current
criteria for the diagnosis of HFpEF rely on the demonstration
of at least moderate resting diastolic dysfunction1; however,
we and others, have emphasized the dynamic nature of left
ventricular (LV) diastolic performance during exercise.6,7 Left
ventricular active relaxation is a highly energy dependent
process.8 In health, the rate of LV active relaxation increases
during exercise, maximizing the efﬁcacy of diastolic ﬁlling in
the context of a shorter diastolic duration at high heart
rates.9 We have previously shown that patients with HFpEF
demonstrate a profound impairment, or indeed a reversal, of
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this physiological increase in LV active relaxation rate on
exercise, because of a combination of cardiac energetic
impairment and vasculo-ventricular mismatch.6 This impair-
ment of diastolic ﬁlling leads to a marked increase in left
ventricular end-diastolic pressure (LVEDP) and pulmonary
artery pressure (PAP) on exercise in patients with HFpEF,
even though resting LVEDP may be normal or near normal.7 A
corollary of this is that resting diastolic dysfunction alone
may not be a reliable indicator of impaired diastolic
performance on exercise.6,10
In experimental models of acute pulmonary hypertension
(PHT), the associated increase in right ventricular diastolic
volume stretches the pericardium, increasing pericardial pres-
sure. Diastolic ﬁlling of the left ventricle is then constrained by
the pericardium (pericardial constraint), and by the right
ventricle via the interventricular septum (diastolic ventricular
interaction, DVI). In an experimental model, the position and
shape of the interventricular septum at end-diastole was shown
to be highly correlatedwith the pressure difference between the
2 ventricles at end-diastole, which reﬂects the true LV
“preload”.11 As there is normally a signiﬁcant LV-right ventric-
ular (RV) pressure difference at end-diastole in health, the
septum is convex towards the right, but as this trans-septal
gradient falls and DVI develops, the septum becomes ﬂatter at
end-diastole.12–14 The tight relationship between end-diastolic
radius of curvature and end-diastolic trans-septal pressure
gradient has also been conﬁrmed in the human heart.15 We
previously demonstrated substantial DVI in an experimental
model of systolic heart failure,16 and also important DVI in
40% of patients with HFrEF.17
We hypothesized that, similar to these acute experimental
models of RV pressure overload, the acute increase in PAP
occurring during exercise in patients with HFpEF would also
lead to the development of DVI, further aggravating the
abnormal diastolic ﬁlling in these patients and exacerbating
the impairment of the Frank-Starling mechanism.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request. Thirty
consecutive patients with clinically stable HFpEFwere recruited
from a community-based echocardiography study to investi-
gate the incidence of HFpEF in people in the UK aged
>60 years.18 Patients had clinical features of heart failure
(New York Heart Association class II symptoms or greater), LV
ejection fraction ≥50%, and echocardiographic evidence of
diastolic dysfunction (and no signiﬁcant valvular disease) as per
the European Society of Cardiology (ESC) guidelines at the time
of study initiation.19 All patients were invited for cardiopul-
monary exercise testing. In patients with borderline diastolic
parameters (resting E/E0 8–15), the diagnosis of HFpEF
required the additional conﬁrmation of objective evidence of
exercise limitation (peak oxygen consumption, VO2, <85% of
predicted normal), and a pattern of gas exchange indicating a
cardiac basis for the exercise limitation (VE/VCO2 slope >34,
VO2 at anaerobic threshold <40%, and normal breathing
reserve).20 Predicted values for peak VO2 for age and sex were
taken from a statement on exercise standards from the writing
group of the American Heart Association.21 No patients had left
or right bundle branch block on ECG. Patients with atrial
ﬁbrillation were excluded on the basis of varying diastolic ﬁlling
times, which would have introduced inaccuracies into the
measurement of septal normalized radius of curvature and
required averaging over numerous beats.
Age and sex matched HT controls were recruited from
hypertension clinics at the Aberdeen Royal Inﬁrmary, Aberdeen,
UK, and the Norfolk and Norwich University Hospitals, Norwich,
UK. Healthy volunteers were recruited from the community
study and matched for age and sex. All controls underwent
cardiopulmonary exercise testing and had normal exercise
capacity (peak VO2 >90% predicted for age and sex) and normal
resting echocardiograms and ECGs. Patients fasted for at least
4 hours before the exercise tests and avoided caffeine for
24 hours before the study visits. Medications were taken as
usual. The studywas approved by theNorth of ScotlandNational
Health Service (NHS) Research Ethics Committee, Aberdeen,
UK. All procedures were performed in accordance with the
Declaration of Helsinki and followed written informed consent.
Exercise Stress Echocardiography
Semi-supine exercise stress echocardiography (Vivid E-9, GE
Healthcare, Horten, Norway) was undertaken while patients
exercised using an electronically-braked bicycle (E-Bike
ergometer EL, GE Healthcare, Horten, Norway). Peak heart
Clinical Perspective
What Is New?
• This study demonstrates that diastolic ventricular interac-
tion develops with exercise in a non-obese sub-phenotype of
patients with heart failure with preserved ejection fraction.
• Exercise testing is essential in patients with heart failure
with preserved ejection fraction to identify exercise induced
pulmonary hypertension and screen for diastolic ventricular
interaction.
What Are the Clinical Implications?
• Diastolic ventricular interaction represents a novel thera-
peutic target for heart failure with preserved ejection
fraction patients, for whom effective therapies are currently
lacking.
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rate and workload achieved during cardiopulmonary exercise
testing were used to create the exercise protocol for each
subject, aiming to achieve maximum heart rate in 8 to
10 minutes. Echocardiography settings were set to a low
mechanical index of <0.2. Intravenous transpulmonary
echocardiographic contrast (Sonovue, Bracco Imaging SpA,
Colleretto Giacosa, Italy) was then given, and a resting mid-
ventricular parasternal short axis view was obtained below the
mitral leaﬂets, just above the papillary muscle insertion points.
At peak exercise, a further 1 mL Sonovue was injected, and the
parasternal short axis window was recorded as above. Apical 4-
and 2-chamber views were also obtained at rest and peak
exercise to measure LV volumes. No study participants
developed signiﬁcant mitral regurgitation during exercise, as
assessed following lysis of microbubbles with a high mechan-
ical index impulse.
End-Diastolic NRC Measurement
Still images of the mid-ventricle were analyzed by 2 investi-
gators (B.L.L. and V.S.V.) masked to the clinical status of the
subject, and the mean of the measurements from these 2
investigators was used. The intra-observer and inter-observer
variability of diastolic NRC was <10%. The normalized radius
of curvature (NRC) of the left ventricle at end-diastole was
measured using the operator-independent method described
by Dong et al22 (Figure 1), brieﬂy:
1. Images were exported into ImageJ/Fiji (National Institutes
of Health, Bethesda, Maryland, USA);
2. Using the “Septal Radius Calculator” plug-in, LV area (A)
was measured at end-diastole by tracing the endocardial
border (with the papillary muscles included);
3. The “idealized” radius (ri) was then automatically calcu-
lated from A, using the equation for the area of a circle,
ri ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
A=p
p
;
4. The endocardial borders of the septum were then traced
for the left ventricle, and right ventricle between the RV
insertion points, to calculate the septal radius of curvature
(r); and
5. NRC was calculated as the ratio of septal and idealized
radii, r/ri.
Figure 1. Septal ﬂattening from diastolic ventricular interaction causes a D-shaped left ventricle, and can
be quantiﬁed from the normalized radius of curvature. A, A resting contrast echocardiogram in the
parasternal short axis view of the left ventricle of a patient with heart failure with preserved ejection
fraction, demonstrating a circular interventricular septum at end-diastole. B, In the same patient during
exercise, the subsequent development of pulmonary hypertension leads to pericardial constraint and
diastolic ventricular interaction, ﬂattening the septum and resulting in a D-shaped LV. C, The shape of the
left ventricular short axis image is calculated from the ratio of the radius extrapolated from the demarcated
septum (r) to the cavity radius (ri), called the normalized radius of curvature. This is close to 1 at rest. D,
During exercise in patients with diastolic ventricular interaction, the ﬂattened septum produces a calculated
NRC value much >1. LV indicates left ventricle; NRC, normalized radius of curvature; RV, right ventricle.
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Measurement of Left Ventricular End-Diastolic
Volume
LV end-diastolic volume (LVEDV) was measured in apical 4-
and 2-chamber windows at rest and at peak-exercise, by the
Simpson bi-plane method.23
Measurement of Normalized End-Systolic Radius
of Curvature on Exercise
While right ventricular systolic pressure (RVSP) can be mea-
sured relatively accurately at rest using the tricuspid regurgitant
jet velocity plus an assumed right atrial pressure (based on
collapse of the inferior vena cava during inspiration),24 the
assumptions underlying this estimation are no longer valid on
exercise, where intrathoracic pressure excursions are greatly
increased.25 In childrenwith pulmonary hypertension, King et al
demonstrated that the LV end-systolic trans-septal pressure
gradient tightly correlatedwith the inverse of the LV end-systolic
NRC (r/ri) with Pearson’s r=0.86.
26 End-systolic septal radius of
curvature was also previously shown in another study to be
strongly related to RVSP in patients with atrial septal defect.27
While it is possible to estimate absolute RVSP from the formula
described by King et al, because the formula has not been
validated in this patient population, we instead report the
systolic normalized radius of curvature measurements, which
correlate with RVSP. TheNRC at end-systole wasmeasured by 2
investigators (S.K.P. and B.L.L.) blinded to patient clinical status
and the mean of the measurements was used in subsequent
calculations. The intra-observer and inter-observer variability of
systolic NRC was <10%.
Statistical Analysis
Values are expressed as meanSE of the mean (SEM).
Baseline characteristics and outcome measures of the 3
groups were compared using ANOVA for continuous mea-
sures, with Bartlett’s test to assess equality of variance. When
the test was signiﬁcant, each 2-way comparison was tested
using a t test, assuming equal variance if possible, otherwise
unequal variances were used. To control the type-I error rate,
we used Bonferroni adjustment for the 2-way comparisons,
declaring signiﬁcance if the P value was ≤0.017 (ie, 0.053).
The Kruskal–Wallis test was used for non-normally distributed
data, and 2-way comparisons were made using the Mann–
Whitney U test. Categorical variables were compared between
groups using Fisher exact test. The relationship between
variables was assessed using scatter plots and Pearson r, or
Spearman rho where the data were not normally distributed.
All analyses were undertaken using Stata version 14.1/SE
(StatCorp, College Station, TX) and R version 3.2.3 (R
Foundation for Statistical Computing, Vienna, Austria).
Results
Demographics
The baseline characteristics of study participants are shown in
Table 1. HFpEF patients were similar to controls in terms of age,
sex, and cardiovascular risk factors, but were more overweight,
with an average bodymass index of 29.30.7 kg/m2 (P<0.001).
HFpEF patients also had an altered chronotropic response to
exercise, and a higher percentage were on beta-blocker and
aspirin therapy. No patients were on loop diuretic therapy. There
was a trend towards higher resting brain natriuretic peptide (BNP)
levels in HFpEF patients, but this was not statistically signiﬁcant
(P=0.08). Left atrial volume index (LAVI) was not signiﬁcantly
different betweenHFpEF and hypertensive patients (P=0.27), but
both were larger than Healthy controls (P<0.001). However, LV
mass indexed to body surface area (LVMI) was greater in HFpEF
patients compared with hypertensive (P=0.02) and Healthy
controls (P<0.001).
End-Diastolic NRC
As shown in Table 2, resting end-diastolic NRC was similar
across all 3 groups (P=0.80). At peak exercise, NRC increased
signiﬁcantly in HFpEF patients only (DNRC, +0.450.06,
P<0.001), with non-signiﬁcant increases observed in hyperten-
sive (+0.170.05, P=0.38) and Healthy controls (+0.060.03,
P=0.93). DNRC was greater in HFpEF compared to both
hypertensive (P=0.002) and Healthy controls (P<0.001). Peak
NRC was higher in the HFpEF patients (1.540.07) compared
with hypertensive (1.270.06, P=0.004) and healthy controls
(1.140.03, P<0.001). Although there was a trend towards a
higher NRC on exercise in hypertensive versus healthy controls
(P=0.05) this was not statistically signiﬁcant following the pre-
speciﬁed Bonferroni’s adjustment (Figure 2, Table 2). In HFpEF
patients, peak NRC also correlated with LVMI (r=0.33, P<0.05).
End-Systolic NRC
Resting end-systolic NRC was higher in HFpEF patients than
hypertensive controls (1.210.02 versus 1.160.02), and
higher in hypertensive controls compared with healthy
controls (1.160.02 versus 1.110.02), implying higher
resting right ventricular systolic pressures. However, this
difference was statistically signiﬁcant between HFpEF and
Healthy only (P=0.002; Table 3). At peak exercise, end-
systolic NRC was higher in HFpEF patients (1.470.05), and
this was signiﬁcantly higher than hypertensive and Healthy
controls (P=0.0049 and P=0.011, respectively).
End-Diastolic NRC and End-Systolic NRC
There was a positive correlation between peak diastolic NRC
and systolic NRC on exercise in HFpEF (q=0.51, P=0.007)
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Table 1. Baseline Characteristics
HFpEF (n=30) HT (n=17) Healthy (n=17) P Value
Age, y 71.9 (1.2) 69.4 (1.3) 69.2 (1.1) 0.20
Female (%) 22 (73) 7 (41) 8 (47) 0.06
White (%) 30 (100) 17 (100) 17 (100) 1.00
BMI, kg/m2 29.3 (0.7) 26.8 (0.8) 25.0 (0.5) <0.001*
Comorbidities
Hypertension (%) 22 (73) 17 (100) 0 (0) <0.001*
Diabetes mellitus (%) 6 (20) 1 (6) 0 (0) 0.08
IHD (%) 4 (13) 0 (0) 0 (0) 0.09
NYHA Class
1 (%) 0 (0) 17 (100) 17 (100) <0.001*
2 (%) 8 (27) 0 (0) 0 (0)
3 (%) 22 (73) 0 (0) 0 (0)
4 (%) 0 (0) 0 (0) 0 (0)
Medications
Aspirin (%) 13 (43) 2 (13) 0 (0) 0.002†
Beta-blocker (%) 8 (27) 1 (6) 0 (0) 0.02†
ACE-I or ARB (%) 15 (50) 10 (63) 0 (0) <0.001*
MRA or thiazide diuretic (%) 13 (43) 6 (38) 0 (0) 0.002†
Echocardiography
LV ejection fraction, % 64.5 (1.4) 64.2 (1.7) 60.8 (1.6) 0.21
E, m/s 0.7 (0.05) 0.8 (0.07) 0.5 (0.05) 0.004†
A, m/s 0.9 (0.05) 0.9 (0.05) 0.7 (0.02) <0.001*
E/A 0.8 (0.03) 0.9 (0.02) 0.8 (0.05) 0.36
Mitral deceleration time, ms 262.4 (17.5) 242.0 (11.4) 210.5 (10.0) 0.052
E0 lateral, cm/s 7 (6, 9) 8 (8, 9) 8 (8, 9) 0.53
E/e0average 11 (9, 16) 9 (8, 10) 8 (6, 9) <0.001*
LA volume index, mL/m2 42.2 (3.8) 52.5 (4.2) 28.8 (2.5) <0.001*
LVMI, g/m2 96.5 (4.5) 72.2 (4.9) 64.1 (3.7) <0.001*
BNP, pg/mL 60.9 (22.1, 93.1) 13.6 (11.3, 39.4) 15.7 (12.3, 54) 0.08
Exercise
Resting heart rate, bpm 75.5 (2.0) 78.6 (2.7) 73.2 (2.6) 0.35
Peak exercise heart rate, bpm 112.1 (3.2) 121.9 (3.2) 128.7 (3.1) 0.003†
Resting diastolic BP, mm Hg 83.7 (2.4) 83.2 (2.4) 81.7 (2.6) 0.85
Resting systolic BP, mm Hg 147.2 (3.7) 144.2 (4.2) 128.4 (4.6) 0.007†
Peak diastolic BP, mm Hg 84.4 (2.8) 87.9 (2.4) 88.2 (3.6) 0.62
Peak systolic BP, mm Hg 170.9 (5.2) 195.3 (5.3) 201.3 (8.0) 0.001†
Exercise duration, min 10.9 (0.6) 13.5 (0.8) 11.4 (0.3) 0.12
FEV1, L 2.24 (0.10) 2.40 (0.24) 2.46 (0.12) 0.17
Peak VO2/predicted peak VO2, % 61.1 (2.3) 97.6 (3.0) 98.4 (1.7) <0.001*
VO2 at AT/predicted peak VO2, % 34.2 (0.9) 64.3 (2.0) 56.5 (2.4) <0.001*
VE-VCO2 at AT 38.7 (0.9) 29.9 (1.1) 27.6 (0.6) <0.001*
Respiratory exchange ratio 1.13 (0.02) 1.14 (0.02) 1.11 (0.01) 0.49
Values are mean (SEM) or median (interquartile range). A indicates atrial ﬂailing velocity; ACE-I, angiotensin converting enzyme inhibitor; AF, atrial ﬁbrillation; ARB, angiotensin receptor
blocker; AT, anaerobic threshold; BMI, body mass index; BNP, brain natriuretic peptide; BP, blood pressure; E, early transmitral ﬂow velocity; E0 , mitral annular velocity; FEV1, forced
expiratory volume over 1 second; HFPEF, heart failure with preserved ejection fraction; HT, hypertensive control; IHD, ischemic heart disease; LV, left ventricle; MRA, mineralocorticoid
receptor antagonist; NYHA, New York Heart Association; VCO2, carbon dioxide production; VE, minute ventilation; VO2, oxygen consumption.
*P<0.001.
†P<0.05.
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(Figure 3). A positive correlation was also seen in hyperten-
sive controls (q=0.60, P=0.01), but there was no signiﬁcant
correlation in healthy controls (q=0.14, P=0.61).
End-Diastolic NRC and Cardiac Volumes
LVEDV was similar at rest in all 3 groups (Table 4). LVEDV
increased with exercise in Healthy controls (DLVEDV,
+8.82.0 mL, P<0.001) and in hypertensive controls
(+6.12.4 mL, P=0.001). However, LVEDV failed to increase
appropriately during exercise in HFpEF (+1.51.8 mL,
P=0.71), and indeed fell in 13 patients. The change in LVEDV
was signiﬁcantly different between HFpEF and healthy
(P<0.001) and HFpEF and hypertensive (P=0.014) controls.
In the HFpEF patient group, there was a modest negative
correlation between DLVEDV and peak NRC (r=0.40,
P=0.046; Figure 4A).
Stroke volume (SV) was also similar at rest in all 3 groups
(Table 4). SV increased in healthy (DSV, +10.71.7 mL,
P<0.0001) and hypertensive controls (+9.61.8 mL,
P<0.0001) on exercise, but failed to increase appropriately
in HFpEF (+1.01.4 mL, P=0.05). Indeed, SV fell in the 13
HFpEF patients who failed to increase their LVEDV. In HFpEF
patients, DSV trended towards a modest negative correlation
with DNRC (r=0.36, P=0.08; Figure 4B). There was also a
trend towards a positive correlation between peak heart rate
and DSV in the whole patient group (n=64; r=0.22, P=0.09),
however this was lost when considering the HFpEF group
alone (r=0.05, P=0.79).
Discussion
In this study, we show that, during exercise, marked ﬂattening
of the interventricular septum occurs at end-diastole in HFpEF
patients, but not in hypertensive or normotensive controls,
indicating the development of DVI. The degree of DVI was
modestly inversely correlated with the increase in LVEDV on
exercise. Our ﬁndings suggest that DVI is an important
mechanism aggravating the pre-existing diastolic abnormality
in HFpEF, contributing to the limitation of utilization of the
Frank-Starling mechanism on exercise, and to exercise
limitation.
HFpEF is poorly understood, and no established therapies
exist, despite its estimated economic burden of $54 billion
annually worldwide.28 The HFpEF syndrome represents a
range of underlying etiologies and these may present clinically
as a number of sub-phenotypes.29 These differing sub-
phenotypes are likely responsible for the heterogeneity in
response to interventions30,31 and, by extension, the disap-
pointing results of clinical trials in the area to date. This has
prompted many to advocate for sub-phenotype-based treat-
ment regimens to improve patient outcomes32 and for careful
and thorough characterization of patients enrolled in studies
Table 2. End-Diastolic NRC at Rest and Peak Exercise
HFpEF (n=30 HT (n=17) Healthy (n=17) P Value (Overall)
P Values for 2-Way Comparisons if Overall Signiﬁcant
HFpEF vs HT HFpEF vs Healthy HT vs Healthy
NRC (dias) rest 1.09 (0.01) 1.10 (0.02) 1.09 (0.02) 0.80
NRC (dias) peak exercise 1.54 (0.07) 1.27 (0.06) 1.14 (0.03) 0.0001 0.006* 0.0001* 0.241
DNRC (dias)† 0.45 (0.06) 0.17 (0.05) 0.06 (0.03) 0.0001 0.0014* 0.0001* 0.472
Values are mean (SEM). HFpEF indicates heart failure with preserved ejection fraction; HT, hypertensive controls; NRC, normalized radius of curvature; DNRC, change in normalized radius
of curvature.
*P(adjusted)≤0.017.
†The change in end-diastolic NRC on exercise was signiﬁcant for HFpEF patients (P<0.001), but not hypertensive (P=0.38) or normotensive controls (P=0.93).
Figure 2. Change in end-diastolic normalized radius of curva-
ture with exercise by patient group. Boxplots show the change in
NRC with exercise, with raw data overlaid. The change in end-
diastolic NRC with exercise was signiﬁcantly higher in HFpEF
patients compared with normotensive (HFpEF vs healthy,
P<0.001) and hypertensive controls (HFpEF vs HT, P=0.002).
There was a trend towards a difference between HT and healthy
controls, but this was not statistically signiﬁcant (P=0.07).
†P<0.001, *P<0.05. HFpEF indicates heart failure with preserved
ejection fraction; HT, hypertensive controls; NRC, normalized
radius of curvature.
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involving patients with HFpEF. Primary abnormalities of LV
active relaxation, increased passive LV stiffness (because of
myocardial ﬁbrosis, glycation of collagen, titin isoform shift
and impaired titin phosphorylation), and impaired atrial
mechanical function, may each contribute to impaired dias-
tolic ﬁlling at rest in HFpEF.5,33 This results in raised LVEDP
and an impaired ability to use the Frank-Starling mechanism
to increase stroke volume. However, as we have previously
demonstrated, there is profound dynamic impairment of LV
active relaxation during exercise,4,6 even in patients with mild
elevations of LVEDP at rest. The Mayo group have therefore
advocated exercise hemodynamic studies in the diagnosis
and evaluation of patients with the endophenotype of near-
normal resting LVEDP.7 Others have advocated stress
echocardiography to assess changes in E/E0 to estimate
dynamic changes in LVEDP.34
PHT is common in HFpEF, being present in >80% of patients
and strongly associated with mortality in a community-based
study of 244 patients.35 While much of this PHT is accounted
for by post-capillary factors, a signiﬁcant number of patients
also demonstrate a pre-capillary component, because of
remodeling of the pulmonary arterioles.36 PAP increases
substantially on exercise in association with substantial
increases in LVEDP, even in some patients without signiﬁ-
cantly raised LVEDP or PAP at rest.7 This results in abnormal
RV-pulmonary artery coupling with exercise in HFpEF, and
associated substantial elevation of right atrial pressure
attributable to RV dysfunction.37,38 Our data are consistent
with these studies, showing that the end-systolic NRC
(correlated with RVSP) was moderately increased at rest, but
much more markedly increased on exercise in HFpEF versus
controls. Our ﬁndings are consistent with, but extend those of
a recent paper in which HFpEF patients with a pulmonary
hypertension sub-phenotype, particularly those with a pre-
capillary component, were shown to develop a paradoxical fall
in LV end diastolic transmural pressure gradient on exercise.39
Our study shows that even patients with only mildly increased
resting end-systolic NRC (implying mildly increased resting
RVSP) may develop severe DVI on exercise.
In health, pericardial pressure is little more than zero, and
the end-diastolic pressure of the thin-walled RV is similar.40
However, the pericardium exhibits a J-shaped stress-strain
relationship, and pericardial pressure (and right ventricular
end diastolic pressure) markedly increases as the pericardium
becomes stretched.41 Thus, in experimental models of acute
PHT, such as pulmonary artery banding or massive pulmonary
embolism, pericardial pressure and right ventricular end
diastolic pressure become markedly increased.42,43 In this
setting, even though LVEDP may be raised, LV ﬁlling is
constrained by the pericardium and by the RV through the
interventricular septum which becomes ﬂattened at end-
diastole (DVI). The pericardium can grow in response to
chronic cardiac enlargement, which prevents the development
of pericardial constraint, at least at rest.41 Nevertheless, we
showed that in chronic HFrEF 40% of patients exhibited
evidence of DVI at rest, presumably because of progressive
Table 3. End-Systolic NRC at Rest and Peak Exercise
HFpEF (n=30) HT (n=17) Healthy (n=17) P Value (Overall)
P Values for 2-Way Comparisons if Overall Signiﬁcant
HFpEF vs HT HFpEF vs Healthy HT vs Healthy
NRC (sys) rest 1.21 (0.02) 1.16 (0.02) 1.11 (0.02) 0.004 0.092 0.002* 0.032
NRC (sys) peak exercise 1.47 (0.05) 1.31 (0.04) 1.19 (0.02) 0.0001 0.0049* 0.0001* 0.011*
DNRC (sys)† 0.26 (0.03) 0.15 (0.04) 0.08 (0.03) 0.0015 0.022 0.0005* 0.428
Values are mean (SEM). HFpEF indicates heart failure with preserved ejection fraction; HT, hypertensive controls; NRC, normalized radius of curvature.
*P(adjusted)≤0.017.
†End-systolic NRC increased in all groups with exercise; this was signiﬁcantly greater in HFpEF patients compared with hypertensive and healthy controls.
Figure 3. Change in systolic normalized radius of curvature
(NRC) vs diastolic NRC with exercise. A scatter plot with individual
linear best-ﬁt lines for each group. There was a positive correlation
between the change in end-diastolic NRC and change in systolic
NRC in HFpEF patients (q=0.51, P=0.007), representing a greater
increase in right ventricular systolic pressure in those patients with
increasing diastolic NRC with exercise. A positive correlation was
also seen in hypertensive controls (q=0.78, P=0.01), but not in
healthy controls (q=0.14, P=0.61). HFpEF indicates heart failure
with preserved ejection fraction; HT, hypertensive controls; NRC,
normalized radius of curvature.
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enlargement of the ventricles.17 Recently, Obokata et al
demonstrated DVI in an obese (body mass index ≥35 kg/m2)
HFpEF patient population.44 They showed that, compared with
a non-obese HFpEF group and controls, obese HFpEF patients
displayed plasma volume expansion and right ventricular
dilatation, and had greater RV dysfunction and biventricular
remodeling. DVI was apparent at rest in the obese HFpEF
patients, but not in the non-obese HFpEF or control groups, and
this increased with rising pulmonary artery systolic pressure
with exercise, likely contributing to the profound exercise
intolerance in this group.44
In the current study, we conﬁrmed our hypothesis that the
development of PHT on exercise would lead to the development
of DVI in patients with HFpEF. At rest, the end-diastolic NRCwas
similar in patients and hypertensive and normotensive controls,
and was close to 1, indicating that the left ventricle was almost
circular in the short axis; however, on exercise it substantially
increased in patients with HFpEF but not in the control groups.
These observations indicate a reduction in the end-diastolic
trans-septal pressure gradient, reducing the effective LV
preload and, via the Frank-Starling mechanism, the stroke
volume. Consistent with this, LVEDV increased during exercise
in normotensive and hypertensive controls, but remained
unchanged in patients. Indeed, LVEDV fell in 13 HFpEF patients.
The change in LVEDV during exercise exhibited a modest
negative correlation with peak end-diastolic NRC on exercise,
and a trend was seen with SV, indicating contribution of the
development of DVI to the loss of the Frank-Starlingmechanism
on exercise. While the mean change in LVEDV on exercise was
close to zero in patients, the standard deviation was wide,
indicating substantial heterogeneity in response (Table 4). It is
noteworthy that some of the hypertensive population had
“intermediate” resting E/E0 values, comparable with those seen
in many of the HFpEF patients. These patients had no evidence
of exercise limitation on cardiopulmonary exercise testing and
did not develop end diastolic septal ﬂattening on exercise. This
emphasizes the dramatic worsening of diastolic function on
exercise in this HFpEF sub-phenotype, leading to dramatically
different exercise physiology from that of this hypertensive
subpopulation. Importantly, our patients do not ﬁt into the
obese HFpEF sub-phenotype, where DVI has been demon-
strated previously44; they did not have overt volume overload or
raised ﬁlling pressures at rest, and no resting DVI. Our study
complements the ﬁndings of others in patients with the HFpEF
with pulmonary vascular disease phenotype39 by directly
demonstrating the development of septal shift on exercise.
These observations may have therapeutic implications. For
example, agents that can reduce PAP, particularly during
exercise, may be beneﬁcial. We have shown that short-term
intravenous sodium nitrite therapy (50 lg/kg per minute for
5 minutes) improves hemodynamics by increasing stroke
volume and reduces pulmonary vascular resistance without
signiﬁcant effects on mean arterial pressure in patients with
HFrEF.45 This improvement in SV correlated with increasing
LV trans-septal pressure gradient, suggesting potential relief
of pericardial constraint and DVI. In a recent randomized
controlled trial,46 nebulized nitrite failed to increase exercise
capacity, despite previous evidence showing that it improved
rest and exercise hemodynamics in HFpEF.47 However,
nebulized nitrite has a short half-life, whereas oral inorganic
nitrate supplementation causes a much more sustained
increase in plasma nitrite.48 Indeed in a small study, 1 week
of beetroot juice (containing 12.9 mmol inorganic nitrate
daily) improved submaximal exercise endurance in patients
with HFpEF.49
Study Limitations
The tricuspid regurgitant jet velocities were not obtained in a
sufﬁcient number of patients in our study to give estimations
of RVSP. Independently of this, as discussed already, the use
of tricuspid regurgitant jet velocities with exercise-stress
echocardiography to estimate RVSP is problematic, and
rendered invalid because of marked swings in intrathoracic
Table 4. Cardiac Volume Analysis at Rest and Peak Exercise
HFpEF (n=30) HT (n=17) Healthy (n=17) P Value (Overall)
P Values for 2-Way Comparisons if Overall Signiﬁcant
HFpEF vs HT HFpEF vs Healthy HT vs Healthy
LVEDV rest, mL 91.6 (3.1) 104.1 (5.0) 90.5 (3.9) 0.04 0.03 0.83 0.04
LVEDV peak exercise, mL 93.1 (3.3) 111.5 (5.2) 99.3 (4.0) 0.008 0.003* 0.24 0.07
DLVEDV, mL 1.5 (1.8) 6.1 (2.4) 8.8 (2.0) 0.001 0.01* 0.0006* 0.38
SV rest, mL 59.5 (2.0) 67.6 (3.1) 59.3 (2.5) 0.048 0.03 0.95 0.05
SV peak exercise, mL 63.5 (2.2) 78.2 (3.7) 70.0 (2.6) 0.001 0.0007* 0.06 0.08
DSV, mL 1.0 (1.4) 9.6 (1.8) 10.7 (1.7) <0.0001 <0.001* <0.001* 0.66
Values are mean (SEM). HFpEF indicates heart failure with preserved ejection fraction; HT, hypertensive controls; LVEDV, left ventricular end-diastolic volume; SV, stroke volume; DLVEDV
(mL), LVEDV peak exerciseLVEDV rest; DLVEDV, change in left ventricular end-diastolic volume; DSV (mL), SV peak exerciseSV rest. DSV, change in stroke volume.
*P(adjusted)≤0.017. Patients with HFpEF failed to increase end diastolic volume and therefore stroke volume with exercise, in contrast to hypertensive and healthy controls.
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pressure which preclude estimation of RA pressure.25 Simi-
larly, non-invasive measures of pulmonary vascular resistance,
which provide important information in the diagnosis of PHT,
also require tricuspid regurgitant jet velocities50 and were not
obtained in this study. Invasive measures during right heart
catheterization are considered to be the “gold standard” for
the diagnosis of PHT at rest.25 However, despite evidence that
exercise-derived invasive measures to estimate LV ﬁlling
pressure improve the diagnosis of exercise PHT in HFpEF,7
their use requires standardization and further assessment in
this cohort.51 Additionally, the use of invasive measures in
elderly hypertensive and healthy controls would not have
been possible because of ethical considerations. Kingma et al
demonstrated in a canine model that the end systolic NRC
was tightly correlated with end-systolic transmural pressure
gradient.52 An equation was developed by King et al using
data from children with congenital heart disease and healthy
controls to estimate RVSP from end-systolic NRC.26 However,
this formula has not been validated in an HFpEF patient
population. It is conceivable that the slope of the relationship
between NRC and RVSP could differ if systolic LV stiffness
(end systolic elastance) differed. We have previously shown
that whilst resting LV systolic elastance was increased in
HFpEF patients versus controls, it failed to increase on
exercise appropriately, and exercise LV end systolic elastance
was therefore similar in HFpEF patients and controls.6
Nevertheless we have presented data for end systolic NRC
rather than deriving RVSP in order to make no assumptions.
Catecholamines, such as those released with exercise, have
been shown to diminish the correlation between E/E0 and LV
ﬁlling pressures.53 RV functional assessment and RV-PA
coupling were also not available in our study, and would have
likely required invasive measurements, as non-invasive mea-
sures have not been tested on exercise and require estimations
of exercise pulmonary artery systolic pressure.54 In addition,
targeted ischemia detection with coronary angiography was not
performed in our patient cohort before enrollment, however,
none of the patients had current symptoms of angina or a prior
history of ischemic events, none had ECG changes detected on
exercise testing, and none developedwall motion abnormalities
during the stress echocardiogram, making reversible ischemia
unlikely. Finally, as the HFpEF patients had a slightly higher
body mass index, it is not possible to know whether this may
have played any role in our ﬁndings. However, we feel this would
be unlikely given the small difference in body mass index.
Likewise, we note the small differences in somemedication use
and echocardiographic parameters between the groups. Our
sample size did not allow us to undertake further adjustments,
however, as these patients were recruited from the community
and not ﬂuid overloaded at the time of the study, we would not
anticipate that the small changes seen could have inﬂuenced
the overall results.
Conclusions
Substantial end-systolic ﬂattening of the septum (implying
severe PHT) develops on exercise in a substantial proportion
of HFpEF patients, resulting in DVI and pericardial constraint.
LVEDP during exercise is increased in HFpEF because of
dynamic slowing of LV active relaxation, together with
increased passive LV stiffness.6 The development of DVI in
patients aggravates the diastolic ﬁlling abnormality and
prevents use of the Frank-Starling mechanism to increase
Figure 4. Change in LV volumes vs peak diastolic normalized
radius of curvature on exercise in HFpEF patients. Scatter plots
with linear best-ﬁt lines. A, There was a modest negative
correlation between peak end-diastolic NRC and the change in
LVEDV (ΔLVEDV) on exercise in HFpEF patients (r=0.40,
P=0.046). B, There was also a trend towards a negative
correlation between peak NRC and the change in SV (ΔSV) with
exercise in HFpEF patients, however this did not reach statistical
signiﬁcance (r=0.36, P=0.08). HFpEF indicates heart failure with
preserved ejection fraction; HT, hypertensive controls; LVEDV, left
ventricular end diastolic volume; NRC, normalized radius of
curvature; SV, stroke volume.
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stroke volume on exercise. This has potential therapeutic
implications, potentially with agents that target exercise
pulmonary artery pressure.
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